Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018

Abstract: This economic evaluation study estimates the number of patients with cancer who are eligible for the newly approved drug-indication pairs and projects potential spending and use of the approvals in the United States.